Related Experiment Video
Updated: Feb 17, 2026
07:35
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
12.0K
Clozapine and Gastrointestinal Hypomotility.
1Mental Health Organization North-Holland North, Stationsplein 138, 1703 WC, Heerhugowaard, The Netherlands. d.cohen@ggz-nhn.nl.
CNS Drugs
|December 13, 2017
Summary
Gastrointestinal hypomotility (GIH), a dangerous clozapine side effect affecting 32% of patients, requires vigilant monitoring and proactive management. Early detection through regular questioning and appropriate laxative use is crucial for preventing severe outcomes.
Area of Science:
- Psychiatry
- Gastroenterology
- Pharmacology
Background:
- Gastrointestinal hypomotility (GIH) is a prevalent and serious adverse effect of clozapine treatment.
- GIH significantly impacts patient quality of life and carries a high mortality risk, exceeding that of clozapine-induced agranulocytosis.
- Ileus, a severe form of GIH, has a reported mortality rate of 43.7%.
Purpose of the Study:
- To analyze the prevalence and risks associated with clozapine-induced GIH.
- To evaluate the impact of GIH on patients with therapy-resistant schizophrenia.
- To recommend strategies for the prevention and management of GIH during clozapine therapy.
Main Methods:
- Comprehensive meta-analysis of clozapine-treated patients to determine GIH prevalence.
- Comparative review of lethal side effects associated with clozapine.
- Review of published case reports on clozapine-induced ileus.
Main Results:
- The prevalence of GIH in clozapine-treated patients was found to be 32%.
- GIH poses a significant mortality risk (15.0-27.5%), higher than agranulocytosis (2.2-4.2%).
- Anticholinergic co-prescription increases the incidence and fatality of ileus.
Conclusions:
- Frequent monitoring of bowel function and avoidance of anticholinergics are essential for managing clozapine-induced GIH.
- Preventive laxative prescription or targeted treatment with macrogol, docusate, or senna is recommended.
- Continuous vigilance for GIH is necessary throughout the duration of clozapine treatment due to the risk of severe cases at any time.
Related Concept Videos
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.1K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K
01:20Drugs Affecting GI Tract Motility: Other Laxatives
1.1K
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.1K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.4K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.4K
01:21Drugs for Treatment of Constipation-Predominant IBS
899
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
899
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
476
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
476
01:22Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
620
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
620